Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × Maintenance × Clear all

NCT06503263 2024-09-19

Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse